Evidence map›Paper›PMID 28664941›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2017

Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.

Alessandro Vanoli, Antonio Di Sabatino, Michele Martino, Catherine Klersy, Federica Grillo, Claudia Mescoli, Gabriella Nesi, Umberto Volta, Daniele Fornino, Ombretta Luinetti and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Association between intestinal neoplasms and celiac disease: A review.World journal of gastrointestinal oncology · 2021
    Review
  14. Small Bowel Epithelial Precursor Lesions: A Focus on Molecular Alterations.International journal of molecular sciences · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
  20. Association Between Celiac Disease and Cancer.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Alessandro VanoliDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Antonio Di SabatinoDepartment of Internal Medicine, IRCCS San Matteo Hospital, University of Pavia, Pavia, Italy.
Michele MartinoDepartment of Internal Medicine, IRCCS San Matteo Hospital, University of Pavia, Pavia, Italy.
Catherine KlersyBiometry and Statistics Service, IRCCS San Matteo Hospital, Pavia, Italy.
Federica GrilloPathology Unit, Department of Surgical and Diagnostic Sciences, San Martino/IST University Hospital, Genova, Italy.
Claudia MescoliPathology Unit, Department of Medicine, University of Padua, Padua, Italy.
Gabriella NesiDivision of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Umberto VoltaDivision of Gastroenterology, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Daniele ForninoDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Ombretta LuinettiDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Paolo FocianiUnit of Pathology, Luigi Sacco University Hospital, Milan, Italy.
Vincenzo VillanacciPathology Section, Spedali Civili Hospital, Brescia, Italy.
Francesco P D'ArmientoDepartment of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy.
Renato CannizzaroDepartment of Gastroenterology, National Cancer Institute, Aviano, Italy.
Giovanni LatellaGastroenterology Unit, Department of Life and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Carolina CiacciDepartment of Medicine and Surgery, University of Salerno, Salerno, Italy.
Livia BianconeDepartment of Systems Medicine, University of Tor Vergata, Rome, Italy.
Marco PaulliDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Fausto SessaDepartment of Surgical and Morphological Sciences, University of Insubria, Varese, Italy.
Massimo RuggePathology Unit, Department of Medicine, University of Padua, Padua, Italy.
Roberto FioccaPathology Unit, Department of Surgical and Diagnostic Sciences, San Martino/IST University Hospital, Genova, Italy.
Gino R CorazzaDepartment of Internal Medicine, IRCCS San Matteo Hospital, University of Pavia, Pavia, Italy.
Enrico SolciaDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-familial small bowel carcinomas are relatively rare and have a poor prognosis. Two small bowel carcinoma subsets may arise in distinct immune-inflammatory diseases (celiac disease and Crohn's disease) and have been recently suggested to differ in prognosis, celiac disease-associated carcinoma cases showing a better outcome, possibly due to their higher DNA microsatellite instability and tumor-infiltrating T lymphocytes. In this study, we investigated the histological structure (glandular vs diffuse/poorly cohesive, mixed or solid), cell phenotype (intestinal vs gastric/pancreatobiliary duct type) and Wnt signaling activation (β-catenin and/or SOX-9 nuclear expression) in a series of 26 celiac disease-associated small bowel carcinoma, 25 Crohn's disease-associated small bowel carcinoma and 25 sporadic small bowel carcinoma cases, searching for new prognostic parameters. In addition, non-tumor mucosa of celiac and Crohn's disease patients was investigated for epithelial precursor changes (hyperplastic, metaplastic or dysplastic) to help clarify carcinoma histogenesis. When compared with non-glandular structure and non-intestinal phenotype, both glandular structure and intestinal phenotype were associated with a more favorable outcome at univariable or stage- and microsatellite instability/tumor-infiltrating lymphocyte-inclusive multivariable analysis. The prognostic power of histological structure was independent of the clinical groups while the non-intestinal phenotype, associated with poor outcome, was dominant among Crohn's disease-associated carcinoma. Both nuclear β-catenin and SOX-9 were preferably expressed among celiac disease-associated carcinomas; however, they were devoid, per se, of prognostic value. We obtained findings supporting an origin of celiac disease-associated carcinoma in SOX-9-positive immature hyperplastic crypts, partly through flat β-catenin-positive dysplasia, and of Crohn's disease-associated carcinoma in a metaplastic (gastric and/or pancreatobiliary-type) mucosa, often through dysplastic polypoid growths of metaplastic phenotype. In conclusion, despite their common origin in a chronically inflamed mucosa, celiac disease-associated and Crohn's disease-associated small bowel carcinomas differ substantially in histological structure, phenotype, microsatellite instability/tumor-infiltrating lymphocyte status, Wnt pathway activation, mucosal precursor lesions and prognosis.

Indexed as

AdultCarcinomaCeliac DiseaseCrohn DiseaseFemaleHumansIntestinal NeoplasmsIntestine, SmallKaplan-Meier EstimateMaleMiddle AgedProportional Hazards ModelsRetrospective Studies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.